du Bus de Warnaffe A, (2013) Report of the working group on 'the evaluation of the opportunities and challenges associated with innovative therapies' of the Commission on Social Affairs of the Belgian Senate. Senate Documents No 5-1917/1 and 2 (addendum). http://www.senate.be/www/webdriver?MItabObj=pdf&MIcolObj=pdf&MInamObj=pdfid&MItypeObj=application/pdf&MIvalObj=83890320
Pirnay JP, Vanderkelen A, De Vos D, Draye JP, Rose T, Ceulemans C, Ectors N, Huys I, Jennes S, Verbeken G, (2013) Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems. Cell Tissue Bank 14: 525-560
du Bus de Warnaffe A, (2014) Bill amending the Act of 19 December 2008 on the procurement and use of human body material for the purpose of medical human application or scientific research relating to the production of advanced allogeneic therapy. Senate Document No 5-2449/1. http://www.senat.be/www/webdriver?MItabObj=pdf&MIcolObj=pdf&MInamObj=pdfid&MItypeObj=application/pdf&MIvalObj=83890887
Council of Europe (2007) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. http://conventions.coe.int/Treaty/en/Treaties/html/164.htm
Pirnay JP, Vanderkelen A, Zizi M, De Vos D, Rose T, Laire G, Ectors N, Verbeken G, (2010) Human cells and tissues: the need for a global ethical framework. Bull World Health Organ 88: 870-872
Collins S, (2001) Tissue Banks: Is the Federal Government's Oversight Adequate? Hearing before the Committee on Governmental Affairs. Washington, DC: Diane Pub Co
